Research Article

Effect of misoprostol on cervical transition pain in office hysteroscopy: Results of a tertiary center

Volume: 49 Number: 3 September 2, 2022
  • Fatma Ölmez
  • Süleyman Cemil Oğlak *
  • Mehmet Rıfat Göklü
  • Şeyhmus Tunç
  • Mehmet Özer
EN

Effect of misoprostol on cervical transition pain in office hysteroscopy: Results of a tertiary center

Abstract

Objective: Office hysteroscopy is a method that has become increasingly popular because of its low complication rate, rapid recovery, and cost-effectiveness. Pain is the biggest obstacle to the successful completion of office hysteroscopy procedures. Thus, the present study aimed to investigate the efficacy of misoprostol in providing cervical ripening, and thus reducing pain during the cervical transition of hysteroscopy. Methods: This research was conducted as an observational case-control study. Seventy-nine patients who underwent office hysteroscopy were included. Twenty-nine patients were administered 200 μg of vaginal misoprostol 4 h before office hysteroscopy, whereas the control group consisting of 50 patients was not provided with premedication for cervical dilatation. Patients were asked to rate their pain between 0 and 10 using the visual analog scale (VAS) 30 min after the procedure. Results: VAS pain scores after diagnostic office hysteroscopy (3.61 ± 0.61) and operative office hysteroscopy (4.45 ± 0.82) were significantly lower in the misoprostol group than in the control group patients. None of the patients experienced serious side effects caused by misoprostol and requested to end the procedure. Conclusion: A significant reduction in the VAS pain score was detected in patients who were administered 200 μg of vaginal misoprostol 4 h before office hysteroscopy. Misoprostol facilitated transition by providing cervical maturation and reduced the risk of pain-related unsuccessful hysteroscopy.

Keywords

References

  1. 1.Salazar CA, Isaacson KB. Office OperativeHysteroscopy: An Update. J Minim Invasive Gynecol.2018; 25: 199-208.
  2. 2.Amer-Cuenca JJ, Marín-Buck A, Vitale SG, et al.Non-pharmacological pain control in outpatienthysteroscopies. Minim Invasive Ther Allied Technol.2020; 29: 10-9.
  3. 3.Paulo AAS, Solheiro MHR, Paulo COS, Afreixo VMA. What proportion of women refers moderate tosevere pain during office hysteroscopy with a mini-hysteroscope? A systematic review and meta-analysis. Arch Gynecol Obstet. 2016; 293: 37-46.
  4. 4.Abis P, Bigozzi MA, Dotto J, et al. Pain ManagementDuring Office Hysteroscopy: A Survey ofHysteroscopists. Surg Technol Int. 2020; 37: 161-6.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Authors

Fatma Ölmez This is me
Türkiye

Süleyman Cemil Oğlak * This is me
Türkiye

Mehmet Rıfat Göklü This is me
Türkiye

Mehmet Özer This is me
Türkiye

Publication Date

September 2, 2022

Submission Date

June 13, 2022

Acceptance Date

August 11, 2022

Published in Issue

Year 2022 Volume: 49 Number: 3

APA
Ölmez, F., Oğlak, S. C., Göklü, M. R., Tunç, Ş., & Özer, M. (2022). Effect of misoprostol on cervical transition pain in office hysteroscopy: Results of a tertiary center. Dicle Medical Journal, 49(3), 447-454. https://doi.org/10.5798/dicletip.1170154
AMA
1.Ölmez F, Oğlak SC, Göklü MR, Tunç Ş, Özer M. Effect of misoprostol on cervical transition pain in office hysteroscopy: Results of a tertiary center. Dicle Medical Journal. 2022;49(3):447-454. doi:10.5798/dicletip.1170154
Chicago
Ölmez, Fatma, Süleyman Cemil Oğlak, Mehmet Rıfat Göklü, Şeyhmus Tunç, and Mehmet Özer. 2022. “Effect of Misoprostol on Cervical Transition Pain in Office Hysteroscopy: Results of a Tertiary Center”. Dicle Medical Journal 49 (3): 447-54. https://doi.org/10.5798/dicletip.1170154.
EndNote
Ölmez F, Oğlak SC, Göklü MR, Tunç Ş, Özer M (September 1, 2022) Effect of misoprostol on cervical transition pain in office hysteroscopy: Results of a tertiary center. Dicle Medical Journal 49 3 447–454.
IEEE
[1]F. Ölmez, S. C. Oğlak, M. R. Göklü, Ş. Tunç, and M. Özer, “Effect of misoprostol on cervical transition pain in office hysteroscopy: Results of a tertiary center”, Dicle Medical Journal, vol. 49, no. 3, pp. 447–454, Sept. 2022, doi: 10.5798/dicletip.1170154.
ISNAD
Ölmez, Fatma - Oğlak, Süleyman Cemil - Göklü, Mehmet Rıfat - Tunç, Şeyhmus - Özer, Mehmet. “Effect of Misoprostol on Cervical Transition Pain in Office Hysteroscopy: Results of a Tertiary Center”. Dicle Medical Journal 49/3 (September 1, 2022): 447-454. https://doi.org/10.5798/dicletip.1170154.
JAMA
1.Ölmez F, Oğlak SC, Göklü MR, Tunç Ş, Özer M. Effect of misoprostol on cervical transition pain in office hysteroscopy: Results of a tertiary center. Dicle Medical Journal. 2022;49:447–454.
MLA
Ölmez, Fatma, et al. “Effect of Misoprostol on Cervical Transition Pain in Office Hysteroscopy: Results of a Tertiary Center”. Dicle Medical Journal, vol. 49, no. 3, Sept. 2022, pp. 447-54, doi:10.5798/dicletip.1170154.
Vancouver
1.Fatma Ölmez, Süleyman Cemil Oğlak, Mehmet Rıfat Göklü, Şeyhmus Tunç, Mehmet Özer. Effect of misoprostol on cervical transition pain in office hysteroscopy: Results of a tertiary center. Dicle Medical Journal. 2022 Sep. 1;49(3):447-54. doi:10.5798/dicletip.1170154